Previous 10 | Next 10 |
home / stock / chsyf / chsyf news
SHENZHEN, CHINA, May 30, 2023 (GLOBE NEWSWIRE) -- CMS is pleased to announce the NDA of Tildrakizumab Injection under the brand name of ILUMETRI, a monoclonal antibody specifically targeting the p19 subunit of IL-23, has been approved in China. ILUMETRI is indicated for the treatment of adu...
Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation HONG KONG, Apr 26, 2021 - (ACN Newswire) - China Medical System Holdings Limited (0867.HK) ("CMS" or the "Company") has been active in the market ...
China Medical System (0867.HK): Accelerating Development and Stepping to a New Height Driven by Innovation HONG KONG, Apr 2, 2021 - (ACN Newswire) - As the earning season approaches, once again listed pharmaceutical companies are attracting the attention of the public. Recentl...
China Medical System (00867) Ushers in a Revaluation with its Continuous Growth and Synergy between Innovative Business and New Businesses HONG KONG, Mar 30, 2021 - (ACN Newswire) - Turnover and net profit increased at the same time, innovative pipeline continued to expand, an...
China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race HONG KONG, Feb 5, 2021 - (ACN Newswire) - On February 1, China Medical System (0867.HK) announced that its subsidiary had acquired Luqa Ventures Co., Limited ("Luqa"), a dermatology specia...
China Medical System (00867.HK)'s MSCI-ESG Rating Upgraded to "AA", Reaching the Global Leading Level HONG KONG, Dec 22, 2020 - (ACN Newswire) - On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Environmental, Social a...
BEIJING, Feb 28, 2020 - (ACN Newswire) - Professor Li Hongjun, Chairman of the Professional Committee of Infectious Disease Radiology of the Chinese Medical Association Radiology Branch and Director of the Department of Radiology of You'an Hospital, along with members of the committee worked t...
HONG KONG, Feb 20, 2020 - (ACN Newswire) - 1. Targeted by a short seller, China Medical System fought back with a strong response and large-scale buyback In recent years it has been common for short sellers who are active in the Hong Kong stock market to target "high-performing stocks". Howev...
Thinly traded micro cap CytoSorbents (NASDAQ: CTSO ) is up 6% premarket on light volume in reaction to its agreement with China Medical System Holdings ( OTC:CHSYF ) to assess the use of its CytoSorb blood filtration devices in China for critically ill COVID-19 patients. More...
HONG KONG, Feb 14, 2020 - (ACN Newswire) - While the world attention is on the fight against Coronavirus in China, Blue Orca is concerned about other things at the same time. This time, this foreign short selling agency aimed at a high-quality Chinese pharmaceutical company. According to Zhit...
News, Short Squeeze, Breakout and More Instantly...
China Medical Sys Hldgs Company Name:
CHSYF Stock Symbol:
OTCMKTS Market:
SHENZHEN, CHINA, July 16, 2024 (GLOBE NEWSWIRE) -- In July 2024, China Medical System Holdings Limited (“CMS” or the “Group”) has once again been recognized for its outstanding performance and continuous progress in sustainable development. CMS was reincluded in ...
SHENZHEN, CHINA, June 25, 2024 (GLOBE NEWSWIRE) -- On June 25, China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) announced the completion of dosing for the first subject in the phase III bridging t...
SHENZHEN, CHINA, June 18, 2024 (GLOBE NEWSWIRE) -- Innovative drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets (Lumeblue ® ) is an oral diagnostic drug, approved by China’s NMPA for enhancing visualisation of colorectal lesions in adult patients unde...